Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Sabinsa Corporation Granted European Patent for ForsLean®
Company has been granted a patent by the European Patent Office for the use of forskolin, the active compound in the company's ForsLean brand Coleus forskohlii extract.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- Dean Foods Announces Resignation of WhiteWave Foods President Steve Demos
Steve Demos has resigned his position as President of the Company's WhiteWave Foods with Dean Foods Chairman and Chief Executive Officer, Gregg Engles, assuming direct leadership over WhiteWave Foods on an interim basis.
- AMS Health Sciences Announces 2004 Year-End Financial Results
Company reports net sales of $18.5 million for FY04 compared to $18.5 million prior year; 2004 net loss reported at $6.3 million, or $(0.90) per common and diluted share, compared to a net loss of $2.6 million, or $(0.57) per common and diluted share in 2003.
- AMS Health Sciences Announces 2004 Year-End Financial Results
Company reports net sales of $18.5 million for FY04 compared to $18.5 million prior year; 2004 net loss reported at $6.3 million, or $(0.90) per common and diluted share, compared to a net loss of $2.6 million, or $(0.57) per common and diluted share in 2003.
- E.T. Horn Company Selected By Loders Croklaan as Exclusive Distributor of SensoryEffects(TM) Products in Western States
Company signs distribution agreement with Loders Croklaan to represent its line of SensoryEffects(TM) inclusions throughout the western United States.
- E.T. Horn Company Selected By Loders Croklaan as Exclusive Distributor of SensoryEffects(TM) Products in Western States
Company signs distribution agreement with Loders Croklaan to represent its line of SensoryEffects(TM) inclusions throughout the western United States.
- Natrol Announces 2004 Results
Company reports net income of $1.9 million or $0.13 per diluted share compared to a net loss of $1.5 million or $0.11 per share prior year; net sales for 2004 rose 9.1%, from $72.7 million to $79.3 million.
- Natrol Announces 2004 Results
Company reports net income of $1.9 million or $0.13 per diluted share compared to a net loss of $1.5 million or $0.11 per share prior year; net sales for 2004 rose 9.1%, from $72.7 million to $79.3 million.
- Enzymotec Targets South-East Asia Functional Oils Market
Company declares intention of penetrating functional oils market of South-East Asia and Western Pacific.
- Enzymotec Targets South-East Asia Functional Oils Market
Company declares intention of penetrating functional oils market of South-East Asia and Western Pacific.
- EuroPharma and Enzymatic Therapy Sign Licensing and Distribution Agreement
Enzymatic Therapy to take over marketing, sales and dsitribution of Europharma's SneezEze and Renouvelle products.
- EuroPharma and Enzymatic Therapy Sign Licensing and Distribution Agreement
Enzymatic Therapy to take over marketing, sales and dsitribution of Europharma's SneezEze and Renouvelle products.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- NSF International and American Herbal Pharmacopoeia®
Strategic Partnership Raises the Bar on Botanical Industry Standards. NSF International (NSF), an independent, not-for-profit organization, announced a new strategic partnership with American Herbal Pharmacopoeia® (AHP), a California-based non-profit research organization.
- SourceOne(TM) Announces Joint Venture Agreement with American River Nutrition
Company to provide marketng and sales to scientific support, product development and manufacturing contribution of American River Nutrition.
- SourceOne(TM) Announces Joint Venture Agreement with American River Nutrition
Company to provide marketng and sales to scientific support, product development and manufacturing contribution of American River Nutrition.
- Nutritional Laboratories International Signs Equity Deal with Red Diamond Capital
Company finalizes a deal with private equity firm Red Diamond Capital.
- Nutritional Laboratories International Signs Equity Deal with Red Diamond Capital
Company finalizes a deal with private equity firm Red Diamond Capital.
- Glykon Technologies Group Ends HCA Licensing Agreement with Renaissance Herbs
Company has terminated its licensing agreement with Renaissance Herbs, Inc. covering uses and delivery systems for (–)-hydroxycitric acid and related products, effective February 4, 2005.
- Glykon Technologies Group Ends HCA Licensing Agreement with Renaissance Herbs
Company has terminated its licensing agreement with Renaissance Herbs, Inc. covering uses and delivery systems for (–)-hydroxycitric acid and related products, effective February 4, 2005.
- ACNielsen and SPINS Expand Coverage of Fast-Growing Natural Products Industry
Companies announce expansion of SPINSscan Conventional information service tracking sales of natural and organic products across grocery, drug, and mass merchandise retail outlets; For the first time, retailer-specific analysis of natural and organic product sales will be available from the service, and the number of categories tracked will nearly double.
- ACNielsen and SPINS Expand Coverage of Fast-Growing Natural Products Industry
Companies announce expansion of SPINSscan Conventional information service tracking sales of natural and organic products across grocery, drug, and mass merchandise retail outlets; For the first time, retailer-specific analysis of natural and organic product sales will be available from the service, and the number of categories tracked will nearly double.
- Reliv International Announces Executive Promotion
Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects.
- Reliv International Announces Executive Promotion
Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects.
- Reliv International Announces Executive Promotion
Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects.
- Reliv International Announces Executive Promotion
Company announces that Steven D. Albright has been promoted to the office of Vice President and Chief Financial Officer, replacing David Kreher who will be continuing his employment with the company as Director of Special Projects.
- Frutarom Reports 2004 Results
Company reports sales of $196.8 million compared to $139.3 million prior year, with net profit of $15.8 million comparing to $8.0 million.
- Frutarom Reports 2004 Results
Company reports sales of $196.8 million compared to $139.3 million prior year, with net profit of $15.8 million comparing to $8.0 million.
- CortDev, Inc. Signs Letter of Intent to Acquire Botaniex Inc.
As part of the agreement, CDVJ will acquire 100% of the outstanding shares and assets of Botaniex Inc. in exchange for an equity position in CDVJ.
- CortDev, Inc. Signs Letter of Intent to Acquire Botaniex Inc.
As part of the agreement, CDVJ will acquire 100% of the outstanding shares and assets of Botaniex Inc. in exchange for an equity position in CDVJ.
- Natural Health Trends Corp. Announces Fiscal 2004 Results
Company reports Q4 sales of $36.3 million compared to $22.6 million prior year; records net loss of approximately $802,000, or a loss of $0.12 per fully diluted share, versus net income of $1.1 million, or $0.19 per fully diluted share previous year. The decrease in net income was due to higher commissions paid to distributors and selling, general and administrative expenses.
- Natural Health Trends Corp. Announces Fiscal 2004 Results
Company reports Q4 sales of $36.3 million compared to $22.6 million prior year; records net loss of approximately $802,000, or a loss of $0.12 per fully diluted share, versus net income of $1.1 million, or $0.19 per fully diluted share previous year. The decrease in net income was due to higher commissions paid to distributors and selling, general and administrative expenses.
- COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing
Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005.
- COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing
Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005.
- COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing
Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005.
- COOLBRANDS Appoints New Independent Director, Approves Final Breyer's Financing
Company appoints Arthur Waldbaum to serve as a Director; Board approves $40 million in financing for the previously announced acquisition of Breyer's yogurt from Kraft Foods; transaction expected to close March 28, 2005.
- AMS Health Sciences Launches Retail Merchant Division
Retail Merchant Division will sell AMS products through health food stores, spas, gyms, privately owned drug and herb shops, as well as to alternative health practices.
- AMS Health Sciences Launches Retail Merchant Division
Retail Merchant Division will sell AMS products through health food stores, spas, gyms, privately owned drug and herb shops, as well as to alternative health practices.
- Stephen A. Block, Esq. Joins the Board of Directors of Senomyx, Inc.
Stephen A. Block, Esq., former Senior Vice President, General Counsel and Secretary of International Flavors & Fragrances, Inc., has joined the Company's Board of Directors.
- Stephen A. Block, Esq. Joins the Board of Directors of Senomyx, Inc.
Stephen A. Block, Esq., former Senior Vice President, General Counsel and Secretary of International Flavors & Fragrances, Inc., has joined the Company's Board of Directors.
- Stephen A. Block, Esq. Joins the Board of Directors of Senomyx, Inc.
Stephen A. Block, Esq., former Senior Vice President, General Counsel and Secretary of International Flavors & Fragrances, Inc., has joined the Company's Board of Directors.
- Stephen A. Block, Esq. Joins the Board of Directors of Senomyx, Inc.
Stephen A. Block, Esq., former Senior Vice President, General Counsel and Secretary of International Flavors & Fragrances, Inc., has joined the Company's Board of Directors.
- Reliv International Names Managing Director for U.K./Ireland Operations
Company has named Eric J. Vill as the company's new Managing Director for its operations in the United Kingdom and Ireland.
- Reliv International Names Managing Director for U.K./Ireland Operations
Company has named Eric J. Vill as the company's new Managing Director for its operations in the United Kingdom and Ireland.
- Reliv International Names Managing Director for U.K./Ireland Operations
Company has named Eric J. Vill as the company's new Managing Director for its operations in the United Kingdom and Ireland.
- Reliv International Names Managing Director for U.K./Ireland Operations
Company has named Eric J. Vill as the company's new Managing Director for its operations in the United Kingdom and Ireland.
- Gateway Announces International Distribution
Company is in the process of negotiating and signing export and wholesale distribution contracts for a period of 5 years with companies in the health & dietary supplements operating in China, Hong Kong and Indonesia.
- Gateway Announces International Distribution
Company is in the process of negotiating and signing export and wholesale distribution contracts for a period of 5 years with companies in the health & dietary supplements operating in China, Hong Kong and Indonesia.
- New Zealand Milk becomes Fonterra Brands
Company's consumer business, New Zealand Milk, is to be renamed Fonterra Brands.
- New Zealand Milk becomes Fonterra Brands
Company's consumer business, New Zealand Milk, is to be renamed Fonterra Brands.
- AEterna Zentaris Subsidiary Atrium Biotechnologies Files Final Prospectus for $75 Million Initial Public Offering (CDN)
Subsidiary Atrium Biotechnologies Inc. has filed prospectus in connection with an initial public offering and secondary offering of 6,250,000 subordinate voting shares at a price of $12 per share, for total proceeds of $75 million. (CDN)
- AEterna Zentaris Subsidiary Atrium Biotechnologies Files Final Prospectus for $75 Million Initial Public Offering (CDN)
Subsidiary Atrium Biotechnologies Inc. has filed prospectus in connection with an initial public offering and secondary offering of 6,250,000 subordinate voting shares at a price of $12 per share, for total proceeds of $75 million. (CDN)
- Forbes Medi-Tech Announces Financial Results for the 4th Quarter and Year Ended
Company reports revenue of $5.76 million for Q4 compared to $3.93 million prior year; reports total revenue of $17.6 million for FY04, versus $14.3 for 2003, net loss of $0.25 per share for the year.
- Forbes Medi-Tech Announces Financial Results for the 4th Quarter and Year Ended
Company reports revenue of $5.76 million for Q4 compared to $3.93 million prior year; reports total revenue of $17.6 million for FY04, versus $14.3 for 2003, net loss of $0.25 per share for the year.
- Lifeway Foods Reports Year End Results
Company reports sales up 9.7% from $14,878,000 to $16,319,000; Net income was $2,052,000, or 24 cents a share, compared to $2,222,000, or 26 cents a share, for 2003.
- Lifeway Foods Reports Year End Results
Company reports sales up 9.7% from $14,878,000 to $16,319,000; Net income was $2,052,000, or 24 cents a share, compared to $2,222,000, or 26 cents a share, for 2003.
- Pure World Announces Results for 2004
Company reports net income of $635,000 ($.08 per share) compared to revenues of $21,890,000 with a net loss of $245,000 ($.03 per share) in 2003.
- Pure World Announces Results for 2004
Company reports net income of $635,000 ($.08 per share) compared to revenues of $21,890,000 with a net loss of $245,000 ($.03 per share) in 2003.
- Hovid Bhd – Carotech’s Parent Company Enroute to IPO on the Malaysian Securities Exchange Board
Hovid Bhd, the parent company of Carotech Inc, has announced an initial public offering of 24,177,000 shares and made a public issue of 12,800,000 shares at RM1.76 each.
- Hovid Bhd – Carotech’s Parent Company Enroute to IPO on the Malaysian Securities Exchange Board
Hovid Bhd, the parent company of Carotech Inc, has announced an initial public offering of 24,177,000 shares and made a public issue of 12,800,000 shares at RM1.76 each.
- Allergy Research Group, Inc. Reports 2004 Results
Company reports FY04 net income after tax of $1,282,736 versus $1,643,770 prior year, with revenues of $15,136,592, up 11% over 2003.
- Tate & Lyle Interim Results Announcement 2009
Tate & Lyle has announced their 2009 Interim results, reporting the Group's performance, before the impact of exchange translation, remains on track to meet our expectations for the full year.
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- NPI Daily - Top of The News for Nov. 6, 2009 - National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters
Nature's Sunshine Products Reports FY09 Q3 Operating Results; SunOpta Announces FY09 Q3 Results; Tate & Lyle Interim Results Announcement 2009; NOW Foods Receives the 2009 Illinois Governor's Sustainability Award; Transport-C Supports Vitamin Angels at SSW; Cantox at Supplyside West; New Support Showing Immunoglobulin Supplementation Enhances Immune System; FDA Warning: Over-the-Counter Sex Enhancement Drug May Cause 'Dangerously' Low Blood Pressure; EPAX AS Achieves 'Friend of the Sea' Certification; National Organic Standards Board Votes to Crack Down on Organic Personal Care Cheaters; Fast-C™ At SupplySide West: US Clinical Trials Data Available In Booth ; Nutty Flavor & Healthy Boost of Omega-3 Make Hemp Seed an Ideal Ingredient; DSM's tensVida® Recognized for Innovative Development; Nutrition 21 Announces Addition of Innovative New Probiotic + Omega-3 Fish Oil Combination Product; Glanbia Nutritionals Offers More Than Ingredients for Nutritional Beverages; Whole Foods Market(R) Offers Natural Solutions to Help Build Up Body Defenses With Immune System Support; Doug Reyes Joins Embria as Regional Sales Manager; Michael F. Hines Joins Board of General Nutrition Centers, Inc.; Dr. Arnold Hirsch Celebrates 50th Anniversary with the American Chemical Society
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Gencor Announces Study Results
Gencor has announced a new human clinical study was recently completed in Australia on Testofen, Gencor's proprietary extract of fenugreek, to evaluate its effect on libido in healthy men.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Carlson Laboratories Receives Better Nutrition Best of Supplements Awards for 2009
Carlson Laboratories has received awards for three of its products in this year's Best of Supplements Awards presented by Better Nutrition Magazine.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Sharp-GPC™ 45F by Enzymotec
Enzymotec has recently launched a liquid product called Sharp-GPC™ 45F to improve mental function and impede memory related cognitive decline.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Natural Products Foundation Representatives Meet with Federal Regulators on Truth in Advertising Campaign
The Natural Products Foundation recently met with officials from both U.S. Food and Drug Administration and Federal Trade Commission to turn over the names of 10 companies that have continued to make drug or disease claims in their advertising and other promotional materials.
- Taming Fear of the H1N1 Flu Vaccine
- Taming Fear of the H1N1 Flu Vaccine
- Natural Cold and Flu Remedies: Do They Help?
- Natural Cold and Flu Remedies: Do They Help?
- Exercise as Pain Therapy
- Exercise as Pain Therapy
|
QUEBEC CITY, March 23, 2005 – Mr. Renaud Beauchesne, President and CEO of Advitech
Inc. (TSX-V: AVI) will be a presenter at BioMatch 2005, which will be held on March 31, 2005,
at the Fairmount-Queen Elizabeth in Montreal. Mr. Beauchesne’s presentation is scheduled to
begin at 15:40. An update will be provided on XP-828L’s development program, including the
on-going clinical study for psoriasis and the pre-clinical study for inflammatory bowel diseases.
Mr. Beauchesne will also comment on discussions initiated to secure marketing alliances for the
psoriasis market.
BioMatch 2005 is presented as part of BIOMEDEX 2005, the pre-eminent life science industry
conference-exhibition in Canada, which will be held next March 30 and 31 at the Fairmont-The
Queen Elizabeth Hotel. Organized by BIOQuebec and the Association of Health Technologies
Industry (AITS), the event strives to be the ultimate meeting place for the key players working in
the areas of biotechnology, health technology, pharmaceuticals, venture capital, research and
development.will feature presentations by the CEOs from 40 emerging life science companies
from across Canada and the US.
About Advitech
Advitech is a biotechnology company specializing in the development of bioactive ingredients
from dairy proteins. Its key focus areas are in the fields of immunology and inflammation. Its
main platform, XP-828L, is a growth factor complex used as an oral product for mild to moderate
psoriasis and also for other immune-mediated chronic inflammatory diseases. Advitech’s
common shares are listed on the TSX Venture Exchange under the symbol AVI. The number of
common shares outstanding is 54,799,818.
- 30 -
This press release contains forward-looking statements which reflect the Company's current expectations
regarding future events. The forward-looking statements involve risks and uncertainties. Actual results
could differ materially from those projected herein. The reader is cautioned not to rely on these forwardlooking
statements.
The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.
For further information, please contact:
Michel Lamontagne, MBA
Vice President and Chief Financial Officer
(418) 686-7498 ext. 237
m.lamontagne@advitech.com
www.advitech.com |